Table 2. Comparison of the study population laboratory tests and ultrasound examination among different polycystic ovary syndrome phenotypes groups.
| Variables | Phenotypical group | p-value | |||
|---|---|---|---|---|---|
| A HA+AO+PCO (n=113) |
B AO+HA (n = 5) |
C HA+PCO (n = 74) |
D AO+PCO (n = 16) |
||
| LH, IU/L | 7.3 ± 4.5 | 6.4 ± 4.0 | 7.9 ± 6.8 | 5.9 ± 2.9 | 0.553 |
| FSH, IU/L | 6.2 ± 2.7 | 6.1 ± 1.4 | 6.4 ± 3.0 | 5.16 ± 2.0 | 0.511 |
| TSH, mIU/L | 2.6 ± 2.1 | 7.7 ± 14.1 | 2.2 ± 1.8 | 2.0 ± 1.4 | 0.370 |
| TG, mg/dL | 124.2 ± 66.7 | 237.4 ± 144.6 | 123.1 ± 64.3 | 140.3 ± 104.4 | 0.006* |
| Cholesterol, mg/dL | 176.5 ± 33.8 | 180.6 ± 45.8 | 174.3 ± 36.3 | 182.7 ± 33.1 | 0.802 |
| LDL, mg/dL | 106.0 ± 28.2 | 87.4 ± 40.5 | 104.9 ± 30.2 | 111.8 ± 31.5 | 0.492 |
| HDL, mg/dL | 47.7 ± 14.7 | 39.0 ± 6.4 | 47.59 ± 14.7 | 46.0 ± 17.4 | 0.614 |
| SGOT, mg/dL | 21.3 ± 9.7 | 25.6 ± 7.1 | 21.1 ± 10.6 | 19.0 ± 7.3 | 0.636 |
| SGPT, mg/dL | 21.8 ± 13.5 | 30.4 ± 12.5 | 19.2 ± 8.7 | 18.7 ± 8.5 | 0.114 |
| Free testosterone, ng/dL | 1.8 ± 1.6 | 2.5 ± 3.3 | 1.1 ± 1.0 | 1.8 ± 1.5 | 0.010* |
| 17-OH progesterone, ng/dL | 1.4 ± 1.0 | 1.2 ± 0.5 | 1.2 ± 1.2 | 1.1 ± 0.8 | 0.664 |
| DHEA-S, ng/dL | 106.9 ± 120.3 | 187.7 ± 370.2 | 82.9 ± 110.9 | 99.9 ± 133.1 | 0.313 |
| ALP, IU/L | 157.2 ± 51.5 | 183.6 ± 72.5 | 164.7 ± 52.0 | 172.3 ± 63.6 | 0.681 |
| Prolactin | 119.2 ± 163.3 | 99.2 ± 117.0 | 151.7 ± 187.2 | 167.1 ± 189.8 | 0.502 |
| Fasting insulin, mg/dL | 13.9 ± 12.7 | 19.4 ± 8.3 | 15.8 ± 17.2 | 20.6 ± 24.2 | 0.415 |
| FBS, mg/dL | 86.4 ± 8.9 | 100.0 ± 4.8 | 87.1 ± 8.6 | 93.6 ± 10.3 | 0.000* |
| HOMA-IR | 3.0 ± 2.8 | 4.8 ± 2.0 | 3.46 ± 3.8 | 4.5 ±5 .1 | 0.297 |
| HOMA-B | 254.8 ± 278.0 | 194.9 ± 94.0 | 253.2 ± 310.5 | 311.6 ± 402.6 | 0.879 |
| QUICK | 0.3 ± 0.1 | 0.3 ± 0.0 | 0.3 ± 0.0 | 0.3 ± 0.0 | 0.190 |
| Right ovary volume | 8.2 ± 3.3 | 7.1 ± 5.0 | 9.1 ± 6.0 | 9.2 ± 4.7 | 0.915 |
| Left ovary volume | 8.1 ± 4.0 | 4.7 ± 2.9 | 8.6 ± 5.6 | 7.4 ± 4.4 | 0.594 |
| Right antral follicle count | 15.8 ± 4.8 | 11.6 ± 7.0 | 15.3 ± 4.7 | 15.3 ± 7.3 | 0.337 |
| Left antral follicle count | 15.3 ± 5.5 | 11.4 ± 7.2 | 15.4 ± 5.0 | 14.2 ± 6.3 | 0.384 |
| 3-hours OGTT | 102.5 ± 19.1 | 127.4 ± 16.5 | 102.5 ± 24.8 | 113.4 ± 26.0 | 0.031* |
| FSH/LH ratio | 1.3 ± 0.8 | 1.0 ± 0.6 | 1.4 ± 1.2 | 1.6 ± 1.9 | 0.501 |
AO: oligo/anovulation; LH: luteinizing hormone; FSH: follicle stimulating hormone; TSH: thyroid stimulating hormone; TG: triglyceride; LDL: low-density lipoprotein; HDL: high-density lipoprotein; SGOT: serum glutamic oxaloacetic transaminase; SGPT: serum glutamic pyruvic transaminase; DHEA-S: dehydroepiandrosterone sulfate; FBS: fasting blood sugar; ALP: alkaline phosphatase; HA: hyperandrogenism; PCO: polycystic ovaries; OGTT: oral glucose tolerance test.
*statistically significant p-values < 0.050; the quantitative variables are presented as mean±standard deviation.